Skip to content

Effects of Different Intraocular Tamponade Agents on the Quality of Visual Rehabilitation after Combined Vitreoretinal and Cataract Surgery in Elderly Patients

Effects of Different Intraocular Tamponade Agents on the Quality of Visual Rehabilitation after Combined Vitreoretinal and Cataract Surgery in Elderly Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500109808
Enrollment
Unknown
Registered
2025-09-25
Start date
2025-10-01
Completion date
Unknown
Last updated
2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients Undergoing Combined Cataract and Vitreoretinal Surgery

Interventions

Gas group:None
Control group:None
Silicone Oil Group:None
Balanced salt solution group:None
Air group:None

Sponsors

Eye Hospital, Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1.Underwent pars plana vitrectomy combined with cataract extraction and intraocular lens implantation; 2.Received implantation of an A1-UV intraocular lens (Eyebright, China); 3.Able and willing to comply with all scheduled postoperative follow-up visits at 1 day, 1 week, 1 month, and 3 months; 4. All patients were included with a single eye, including those with high myopia and long axial length; 5. Patients must be at least 55 years old. ...

Exclusion criteria

Exclusion criteria: 1.History of ocular trauma, posterior capsular rupture, lens dislocation, or postoperative anterior segment complications; 2.Corneal or conjunctival abnormalities, including scarring or dystrophy; 3.Pupil dilation less than 7 mm at the time of imaging, as well as exclusion of patients with poor cooperation; 4.Cases with elevated intraocular pressure (>24 mmHg) during follow-up; 5. Exclude cases of continuous eccentric tearing of the sac during surgery.

Design outcomes

Primary

MeasureTime frame
optical quality;

Secondary

MeasureTime frame
Tilt and Decentration of IOL;

Countries

China

Contacts

Public ContactBin Zheng

Eye Hospital, Wenzhou Medical University

111575@wmu.edu.cn+86 159 6717 8056

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026